FDA inspection
Juno Pharma Canada Inc.: FDA inspection ending Jan 17, 2024
FDA inspection 1227777 · Voluntary Action Indicated (VAI) · Montreal
Key facts
| Inspection ID | 1227777 |
|---|---|
| Firm | Juno Pharma Canada Inc. |
| FEI number | 3004153143 |
| Address | 11177 Hamon St |
| City | Montreal |
| Country | Canada |
| Fiscal year | 2024 |
| Inspection end date | Jan 17, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data